Galderma's Alastin Rolls Out Pigment-Reducing A-LUMINATE BRIGHTENING SERUM

ALASTIN's proprietary PATH-3 Technology helps to minimize the recurrence of surface pigmentation and protect against future damage with continued use.

Galderma’s ALASTIN Skincare is rolling out  A-LUMINATE BRIGHTENING SERUM to help reduce the appearance of surface pigmentation without any harsh, irritating ingredients.

A-LUMINATE BRIGHTENING SERUM contains a multifaceted blend of peptides, antioxidants, and targeted ingredients to allow the skin to appear brighter and create a more even-toned, complexion over time. ALASTIN's proprietary PATH-3 Technology helps to minimize the recurrence of surface pigmentation and protect against future damage with continued use. The innovative formula also complements in-office treatments including chemical peels, lasers, and skin brightening treatments. The lightweight and non-irritating serum is formulated without hydroquinone or retinol and is safe for long-term daily use.

"We are thrilled to add another innovative formulation to our daily skin care product portfolio with the launch of A-LUMINATE Brightening Serum.  Pigmentation is a common skin concern that a lot of consumers’ face and we know it can be a long-term battle to diminish the look of melasma and dark spots,” says Amber Edwards,the  Chief Commercial Officer of ALASTIN in a news release. “The results of our clinical trial indicate that A-LUMINATE is a topical product that provides impressive results to minimize the appearance of dark spots and discoloration without irritation, and it can be used long-term as part of their normal skincare regimen."